About Pathos
Pathos is a company based in Chicago (United States) founded in 2022 by Ryan Fukushima and Eric Lefkofsky. It operates as a AI-as-a-Service, and Professional Services. Pathos has raised $345 million across 2 funding rounds from investors including Revolution, Lightbank and Builders VC. Pathos has completed 1 acquisition, including Rain Oncology. Pathos offers products and services including PathOS Platform. Pathos operates in a competitive market with competitors including Formation Bio, Owkin, BigHat, Benchsci and Predictive Oncology, among others.
- Headquarter Chicago, United States
- Founders Ryan Fukushima, Eric Lefkofsky
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$345 M (USD)
in 2 rounds
-
Latest Funding Round
$283 M (USD), Series D
Apr 17, 2025
-
Investors
Revolution
& 3 more
-
Employee Count
Employee Count
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Pathos
Pathos offers a comprehensive portfolio of products and services, including PathOS Platform. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
AI platform used for drug development optimization strategies.
Unlock access to complete
Funding Insights of Pathos
Pathos has successfully raised a total of $345M across 2 strategic funding rounds. The most recent funding activity was a Series D round of $283 million completed in April 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series D — $283.0M
-
First Round
First Round
(24 Oct 2024)
- Investors Count 4
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr, 2025 | Amount | Series D - Pathos | Valuation |
investors |
|
| Oct, 2024 | Amount | Series C - Pathos | Valuation | New Enterprise Associates |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Pathos
Pathos has secured backing from 4 investors, including venture fund investors. Prominent investors backing the company include Revolution, Lightbank and Builders VC. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Revolution is recognized as a D.C.-based investment firm.
|
Founded Year | Domain | Location | |
|
Tech focused seed & early stage VC firm investing primarily in the US
|
Founded Year | Domain | Location | |
|
Investments are made in technologies that modernize industries like agriculture and construction.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Pathos
Pathos has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Rain Oncology. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Cancer therapeutics targeting MDM2-dependent tumors are developed.
|
2017 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Pathos
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Pathos Comparisons
Competitors of Pathos
Pathos operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Formation Bio, Owkin, BigHat, Benchsci and Predictive Oncology, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
AI-powered drug discovery platform for various diseases
|
|
| domain | founded_year | HQ Location |
An agentic AI platform is developed for biomedical research insights.
|
|
| domain | founded_year | HQ Location |
Antibody therapies are developed through machine learning and synthetic biology.
|
|
| domain | founded_year | HQ Location |
AI platform used for extracting antibody data from scientific papers.
|
|
| domain | founded_year | HQ Location |
AI-based platform for cancer diagnostics and precision medicine is utilized.
|
|
| domain | founded_year | HQ Location |
AI-driven drug discovery platform for the treatment of cancer
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Pathos
Frequently Asked Questions about Pathos
When was Pathos founded?
Pathos was founded in 2022 and raised its 1st funding round 2 years after it was founded.
Where is Pathos located?
Pathos is headquartered in Chicago, United States. It is registered at Chicago, Illinois, United States.
Who is the current CEO of Pathos?
Iker Huerga is the current CEO of Pathos.
Is Pathos a funded company?
Pathos is a funded company, having raised a total of $345M across 2 funding rounds to date. The company's 1st funding round was a Series C of $62M, raised on Oct 24, 2024.
What does Pathos do?
Pathos is engaged in re-engineering drug development through advanced AI technologies. The company operates in the biotechnology sector, leveraging petabytes of oncology data and patient-derived genomic data via its PathOS Platform. Solutions are developed to identify compelling biology and optimize patient selection strategies. Partnerships with biopharmaceutical companies are formed to license or co-develop clinical-stage therapeutics, ensuring efficacious drugs reach patients with significant unmet needs swiftly.
Who are the top competitors of Pathos?
Pathos's top competitors include Owkin, Formation Bio and XtalPi.
What products or services does Pathos offer?
Pathos offers PathOS Platform.
How many acquisitions has Pathos made?
Pathos has made 1 acquisition, including Rain Oncology.
Who are Pathos's investors?
Pathos has 4 investors. Key investors include Revolution, Lightbank, Builders VC, and NEA.